Results for “Drug”

GeekWire Startups Lisa Stiffler Startups

Araceli raises $4.5M for drug discovery tools aimed at reducing animal testing

Oregon-based Araceli Biosciences raised $4.5 million to commercialize cell-imaging tools that help researchers test potential drugs using human cells, with the aim of reducing reliance on animal studies while producing more relevant results.

Read at GeekWire Startups

Just Security Matthew Nagle Geopolitics

Just the Docs: Treasury and State Department Designate Three Guatemalan Drug Trafficking Groups as Terrorists

Treasury sanctions Guatemala’s Los Mendoza and Los Huistas as terrorists while State designates Los Lorenzanas as a Foreign Terrorist Organization.

Read at Just Security

ABC News Geopolitics

US declares three Guatemalan gangs to be terrorist groups, imposes sanctions

The Trump administration has declared three Guatemalan gangs to be terrorist groups for financing violence and crime with proceeds from drug trafficking

Read at ABC News

The Hill Teddy Grant Geopolitics

DJ Khaled shares he lost 90 pounds with help of GLP-1 drug

In October 2025, Khaled experienced a health scare at a concert, which led to a lifestyle change.

Read at The Hill

ABC News

Brother of Mexican cartel leader sentenced to 22 years for drug trafficking plot

A man whose slain brother led one of Mexico’s most violent drug cartels has been sentenced to more than 22 years in U.S. prison for his role in a sprawling drug trafficking conspiracy that brought cocaine and methamphetamine to American streets

Read at ABC News

BioPharma Dive BioPharma Dive staff

Novo submits sickle cell drug; Flagship, Gates Foundation deepen ties

Novo views the medicine, acquired in a billion-dollar deal, as a future blockbuster. Meanwhile, a pair of startups forged an RNA editing pact and Astellas lined up two new trials in pancreatic cancer.

Read at BioPharma Dive

BioPharma Dive Jacob Bell

This week in charts: Brain drugs are back on venture’s minds

Five neurology-focused startups have together raised around $450 million in the last few weeks. Elsewhere, investors had a muted response to the latest cell therapy research.

Read at BioPharma Dive

Viet Nam News (state-run daily)

HCM City uses magic, drama to warn students against disguised drugs

Performing arts and visual exhibits are taking centre stage in HCM City schools to help students spot modern synthetic drugs hidden in everyday snacks and drinks.

Read at Viet Nam News (state-run daily)

Tehran Times (Iranian state-aligned)

Iran calls for stronger anti-drug cooperation with Asia-Pacific countries

TEHRAN – Iran’s anti-narcotics police chief, Iraj Kakavand, has stressed the need to strengthen cooperation between Iran and countries in the Asia-Pacific region to combat drug trafficking and enhance regional security.

Read at Tehran Times (Iranian state-aligned)

Kyiv Post Kyiv Post

SBU General Posts Full $1.5 Million Bail in Ukraine Criminal Network Case

SBU Major General Serhiy Duka, suspected of helping an organized criminal network buy protection from Ukrainian law enforcement, has had UAH 65 million ($1.5 million) in bail posted in the Operation Carthage case. The investigation implicates officials from the SBU, National Police and Prosecutor General’s Office in an alleged scheme involving bribes, drug trafficking, fraudulent call centers and other illegal businesses.

Read at Kyiv Post

Quantum Computing Report Mohamed Abdel-Kareem

Cleveland Clinic, RIKEN, and IBM Cross 12,000-Atom Barrier in Heterogeneous Quantum-Classical Drug Binding Simulations

A collaboration between Cleveland Clinic, RIKEN, and IBM Quantum has achieved the largest heterogeneous quantum-classical (HQC) electronic-structure calculation to date, simulating protein-ligand complexes exceeding 12,000 atoms. This research utilized 156-qubit IBM Heron r2 processors and leadership supercomputers to significantly advance molecular size and fragment energy accuracy in drug binding simulations. The team developed an Embedded Wavefunction (EWF) formalism and…

Read at Quantum Computing Report

BioPharma Dive Gwendolyn Wu

Windward prices $175M IPO to advance China-licensed lung drugs

The Swiss biotech has two prospects it sees as having the potential to outcompete AstraZeneca and Amgen's blockbuster asthma treatment Tezspire.

Read at BioPharma Dive

South China Morning Post Xinmei Shen Geopolitics

Eli Lilly beats Novo Nordisk to China approval for first oral GLP-1 weight-loss drug

China has approved US pharmaceutical giant Eli Lilly’s weight-loss pill orforglipron, making it the country’s first available oral GLP-1 treatment for obesity as global drug makers seek to tap the country’s massive weight-management market. China’s National Medical Products Administration announced the approval on Thursday, saying that the once-daily pill, marketed as Foundayo, could be used for chronic weight management by obese or overweight adults. GLP-1 receptor agonists…

Read at South China Morning Post

PBS News Politics Matthew Perrone, Associated Press Geopolitics

WATCH: Trump administration officials announce PTSD research funding for psychedelic drug ibogaine

Federal officials on Thursday announced new funding to explore the medical potential of ibogaine, a controversial psychedelic drug championed by veterans, conservative lawmakers and podcasters aligned with President Donald Trump.

Read at PBS News Politics

GEN (Genetic Engineering & Biotechnology News) Sophia Ktori

High Frequency of Drug-Impacting Gene Variants Found in All of Us Cohort

A study finds that everyone in a diverse, nearly 100,000-person sample carried at least one genetic variant that affects how their body processes medications, and a quarter of those people had been prescribed a medication that is known to be impacted by the variant they carried.

Read at GEN (Genetic Engineering & Biotechnology News)

BioPharma Dive Jonathan Gardner

Blackstone bets $1.5B on Pfizer’s obesity drug

The deal will support a sprawling Phase 3 program for a monthly GLP-1 shot Pfizer acquired by winning a bidding war for the drug’s previous owner, Metsera.

Read at BioPharma Dive

The Hill Sreedhar Potarazu, opinion contributor Geopolitics

The risk of blindness from GLP-1 drugs is too serious to ignore

When a medication is prescribed to millions of people, even an uncommon complication can affect a substantial number of individuals.

Read at The Hill

NBC News David Cox

For alpha-gal patients, allergy drug could cut the severity of reactions to red meat

There’s emerging evidence that the allergy drug omalizumab may reduce severe allergic reactions for alpha-gal syndrome, a red meat allergy triggered by a tick bite.

Read at NBC News

The Guardian World Kiran Stacey

‘A second chance’: children guilty of serious offences will no longer have to declare criminal records

Government proposal aims to reduce number of children in custody in England and Wales and boost youth employment Children found guilty of robbery, dealing drugs to other children or violent disorder will no longer have to disclose their criminal records to prospective employers under sweeping government proposals to change the youth justice system. People in England and Wales will not have to share records of crimes committed when they were under 18 for the rest of their…

Read at The Guardian World

STAT Biotech Adam Feuerstein

STAT+: Alnylam, once in the hunt to be a $100 billion biotech, needs to solve its heart drug problem

Alnylam is heavily dependent on its heart drug Amvuttra for growth — and sales have been slowing.

Read at STAT Biotech

South China Morning Post Xinmei Shen Geopolitics

Former ByteDance AI scientist touts drug-discovery model that tops world leaders

A former ByteDance artificial intelligence scientist’s new venture has released a life sciences AI model that the firm claims outperforms state-of-the-art systems, intensifying the increasingly crowded competition in AI-driven drug discovery. Geodesic Intelligence’s NovaAtom-Lite, an AI model designed to predict the structures and interactions of biomolecules, topped a third-party benchmark in several drug discovery tasks, founder Quanquan Gu said on social media on…

Read at South China Morning Post

Al Jazeera Geopolitics

Bolivia arrests former judge on suspicion of drug trafficking

Arrests in Bolivia linked to a US-backed security alliance crackdown on drug cartels in Latin America.

Read at Al Jazeera

Nature Biotechnology Sojin Bing

A comprehensive analysis of CBER experience with AAV gene therapy IND submissions

Nature Biotechnology, Published online: 12 November 2026; doi:10.1038/s41587-026-03378-9 An analysis of Investigational New Drug (IND) submissions to the US Food and Drug Administration (FDA) from 1995 to 2025 reveals a rapid growth in adeno-associated virus (AAV) development over three decades and highlights common reasons for regulatory holds that should be considered for successful product development.

Read at Nature Biotechnology

STAT Biotech Elaine Chen

STAT+: Most-favored nations policy makes drugmakers rethink launches abroad

Drug companies seem to be looking for workarounds to protect their U.S. sales against Trump's "most-favored nations" policy:

Read at STAT Biotech

Euromaidan Press Zoriana Katola

Russian strikes burn almost six months’ worth of cancer drug for Ukraine — now Kyiv is rethinking how it stores medicine

After months of Russian attacks on warehouses, the state drug buyer is shipping stock out to hospitals and regional depots.

Read at Euromaidan Press

The Hill Nathaniel Weixel Geopolitics

Senate committee sets key vote for Trump FDA nominee

The Senate Health Committee scheduled a key vote next week for Dr. Heidi Overton to serve as commissioner of the Food and Drug Administration (FDA), even as her path forward is not assured. According to a committee press release, the vote on Overton’s nomination is scheduled for Nov. 18. The committee will also vote on...

Read at The Hill

Quantum Computing Report Mohamed Abdel-Kareem

INmune Bio Engages Quantum Computing Inc. to Expand Drug Indication Discovery for XPro

INmune Bio and Quantum Computing Inc. are collaborating to use quantum optimization and AI for drug discovery. QCi's Dirac-3S quantum machine will analyze clinical data to find new disease indications for INmune Bio's neuroinflammation drug, XPro. This partnership aims to identify rare and pediatric disease indications for accelerated FDA review.

Read at Quantum Computing Report

Kyiv Post Anastasiia Bzova Geopolitics

US DEA Aided Ukraine’s Probe Into Police-Protected Drug Ring, Interior Minister Says

Interior Minister Ivan Vyhivskyi said on Nov. 11 that the US Drug Enforcement Administration (DEA) helped Ukraine expose the Khimprom criminal group by sharing operational and analytical information. The announcement follows a NABU and SAPO investigation, published Nov. 4, alleging that SBU and National Police officials helped protect the group.

Read at Kyiv Post

BioPharma Dive Kristin Jensen

Drug price hikes in Germany could push US costs higher, study says

The report comes amid escalating tensions between the U.S. and Germany over drug prices, with several large pharmaceutical companies responding by scaling back investments in the country.

Read at BioPharma Dive

Older stories